Elias Allara

10.1k total citations · 1 hit paper
57 papers, 1.5k citations indexed

About

Elias Allara is a scholar working on Physiology, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Elias Allara has authored 57 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 10 papers in Surgery and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Elias Allara's work include Smoking Behavior and Cessation (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Telomeres, Telomerase, and Senescence (6 papers). Elias Allara is often cited by papers focused on Smoking Behavior and Cessation (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Telomeres, Telomerase, and Senescence (6 papers). Elias Allara collaborates with scholars based in Italy, United Kingdom and Japan. Elias Allara's co-authors include Stephen Burgess, Christopher N. Foley, James R Staley, Joanna M. M. Howson, Fabrizio Faggiano, David J. Pinato, Rohini Sharma, Mario Pirisi, Tadaaki Arizumi and Masatoshi Kudo and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Elias Allara

50 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A robust and efficient method for Mendelian randomization with hundreds of genetic variants

2020 364 citations Stephen Burgess, Christopher N. Foley et al. Nature Communications profile →

Peers

Countries citing papers authored by Elias Allara

Since Specialization

Citations

This map shows the geographic impact of Elias Allara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elias Allara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elias Allara more than expected).

Fields of papers citing papers by Elias Allara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elias Allara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elias Allara. The network helps show where Elias Allara may publish in the future.

Co-authorship network of co-authors of Elias Allara

This figure shows the co-authorship network connecting the top 25 collaborators of Elias Allara. A scholar is included among the top collaborators of Elias Allara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elias Allara. Elias Allara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Burden of cardiovascular diseases in England (2020–24): a national cohort using electronic health records data 2025 ·The Lancet Public Health ·Elias Allara, Wenzhong Shi, Thomas Bolton, (unknown), (unknown), (unknown), Anoop Shah, Christopher Tomlinson, Isabel Walter, Nathalie Conrad, John Danesh, Emanuele Di Angelantonio, (unknown), Kamlesh Khunti, Elena Raffetti, Geneviève Cézard, Spiros Denaxas, Angela Wood, William Whiteley	0
2	Leucocyte telomere length and conduction system ageing 2024 ·Heart ·Stefan van Duijvenboden, Christopher P. Nelson, Zahra Raisi‐Estabragh, Julia Ramírez, Michele Orini, Qingning Wang, Nay Aung, Veryan Codd, Svetlana Stoma, Elias Allara, Angela Wood, Emanuele Di Angelantonio, John Danesh, Nicholas C. Harvey, Steffen E. Petersen, Patricia B. Munroe, (unknown)	0
3	The value of genetic data from 665,460 individuals in managing iron deficiency anaemia and suitability to donate blood 2023 ·Vox Sanguinis ·Jarkko Toivonen, Elias Allara, (unknown), Johanna Castrén, Emanuele Di Angelantonio, Mikko Arvas	1
4	Genetically predicted cortisol levels and risk of venous thromboembolism 2022 ·PLoS ONE ·Elias Allara, (unknown), Stephen Burgess, Susanna C. Larsson	6
5	Correction: Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study 2021 ·British Journal of Cancer ·(unknown), Elias Allara, (unknown), Tadaaki Arizumi, Dominik Bettinger, Mario Pirisi, Lorenza Rimassa, Tiziana Pressiani, Nicola Personeni, Laura Giordano, Masatoshi Kudo, Robert Thimme, Joong‐Won Park, Tamar H. Taddei, David E. Kaplan, Ramya Ramaswami, David J. Pinato, Rohini Sharma	1
6	Shorter leukocyte telomere length is associated with adverse COVID-19 outcomes: A cohort study in UK Biobank 2021 ·EBioMedicine ·Qingning Wang, Veryan Codd, Zahra Raisi‐Estabragh, Crispin Musicha, Vassiliki Bountziouka, Stephen Kaptoge, Elias Allara, Emanuele Di Angelantonio, Adam S. Butterworth, Angela Wood, John R. Thompson, Steffen E. Petersen, Nicholas C. Harvey, John Danesh, Nilesh J. Samani, Christopher P. Nelson	46
7	Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study 2020 ·British Journal of Cancer ·(unknown), Elias Allara, (unknown), Tadaaki Arizumi, Dominik Bettinger, Mario Pirisi, Lorenza Rimassa, Tiziana Pressiani, Nicola Personeni, Laura Giordano, Masatoshi Kudo, Robert Thimme, Joong‐Won Park, Tamar H. Taddei, David E. Kaplan, Ramya Ramaswami, David J. Pinato, Rohini Sharma	17
8	A robust and efficient method for Mendelian randomization with hundreds of genetic variants breakdown → 2020 ·Nature Communications ·Stephen Burgess, Christopher N. Foley, Elias Allara, James R Staley, Joanna M. M. Howson	364
9	[Effectiveness of school-based interventions to prevent traffic accidents: an overview of secondary literature]. 2018 ·PubMed ·C. Guerriero, (unknown), (unknown), (unknown), Silvia Silvestri, (unknown), (unknown), Alessandro Costa, (unknown), Fabrizio Faggiano, Elias Allara	1
10	[Medium- and long-term health effects of the L'Aquila earthquake (Central Italy, 2009) and of other earthquakes in high-income Countries: a systematic review]. 2017 ·PubMed ·Alba Ripoll Gallardo, (unknown), Barbara Pacelli, (unknown), (unknown), Fabrizio Faggiano, Françesco Della Corte, Elias Allara	4
11	[Extended reference collection of publications on L'Aquila (Central Italy) earthquake, 2009-2015]. 2017 ·PubMed ·Barbara Pacelli, Elias Allara	0
12	An educational intervention to promote healthy lifestyles in preschool children: a cluster-RCT 2016 ·International Journal of Obesity ·(unknown), Marco Pasini, (unknown), (unknown), Elias Allara, (unknown)	28
13	The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma 2016 ·Journal of Hepatology ·David J. Pinato, Rohini Sharma, Elias Allara, Clarence Yen, Tadaaki Arizumi, Keiichi Kubota, Dominik Bettinger, Jeong Won Jang, Carlo Smirne, Young Woon Kim, Masatoshi Kudo, Jessica Howell, Ramya Ramaswami, Michela Emma Burlone, Vito Guerra, Robert Thimme, Mitsuru Ishizuka, Justin Stebbing, Mario Pirisi, Brian I. Carr	272
14	Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysis 2016 ·Medical Oncology ·Ramya Ramaswami, David J. Pinato, Keiichi Kubota, Mitsuru Ishizuka, Tadaaki Arizumi, Masatoshi Kudo, Jeong Won Jang, Young Woon Kim, Mario Pirisi, Elias Allara, Rohini Sharma	6
15	Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality 2016 ·Internal and Emergency Medicine ·(unknown), Elias Allara, Filippo Patrucco, Fabrizio Faggiano, (unknown), Piero Emilio Balbo	36
16	[Epidemiology and prevention at the times of the Italian National Prevention Plan 2014-2018]. 2015 ·PubMed ·Fabrizio Faggiano, Roberta Pirastu, Elias Allara, (unknown), Gianluigi Ferrante, Barbara Pacelli, Patrizia Schifano, Carlo Senore, Maria Serinelli	0
17	[Primary prevention of cancer and cardiovascular diseases: an overview of scientific literature]. 2015 ·PubMed ·Fabrizio Faggiano, (unknown), (unknown), Elias Allara	1
18	Are mass-media campaigns effective in preventing drug use? A Cochrane systematic review and meta-analysis 2015 ·BMJ Open ·Elias Allara, Marica Ferri, Alessandra Bò, Antonio Gasparrini, Fabrizio Faggiano	62
19	A school-based peer-led smoking prevention intervention with extracurricular activities: the LILT-LdP cluster randomized controlled trial design and study population. 2014 ·PubMed ·(unknown), Giuseppe Gorini, (unknown), (unknown), (unknown), Giulia Carreras, (unknown), Elias Allara, Paola Angelini, Fabrizio Faggiano	8
20	Decennial trends of social differences in smoking habits in Italy: a 30-year update 2013 ·Cancer Causes & Control ·Giuseppe Gorini, Giulia Carreras, Elias Allara, Fabrizio Faggiano	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact